{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:58:49Z","timestamp":1790099929282,"version":"4.0.1"},"reference-count":370,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["101129095"],"award-info":[{"award-number":["101129095"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.mtbio.2025.101616","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T03:21:08Z","timestamp":1740540068000},"page":"101616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-8770","authenticated-orcid":false,"given":"Meekha","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-9888","authenticated-orcid":false,"given":"Rabah","family":"Boukherroub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-8329","authenticated-orcid":false,"given":"Amitav","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Szunerits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.101616_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/jimaging6120131","article-title":"A survey of deep learning for lung disease detection on medical images: state-of-the-art, taxonomy, issues and future directions","volume":"6","author":"Kieu","year":"2020","journal-title":"Journal of Imaging"},{"key":"10.1016\/j.mtbio.2025.101616_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4168538","article-title":"Deep convolutional neural networks for chest diseases detection","volume":"2018","author":"Abiyev","year":"2018","journal-title":"Journal of Healthcare Engineering"},{"key":"10.1016\/j.mtbio.2025.101616_bib3","series-title":"Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems","first-page":"1","article-title":"Chapter 1 - chronic respiratory diseases: an introduction and need for novel drug delivery approaches","author":"Shukla","year":"2020"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/20477724.2015.1122852","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction","volume":"109","author":"Omrani","year":"2015","journal-title":"Pathog. Glob. Health"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901176","article-title":"Double-layered M2e-NA protein nanoparticle immunization induces broad cross-protection against different influenza viruses in mice","volume":"9","author":"Wang","year":"2020","journal-title":"Adv. Healthcare Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.chest.2022.01.014","article-title":"Global impact of respiratory disease what can we do, together, to make a difference?","volume":"161","author":"Levine Sm","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib8","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.05.020415","article-title":"Global and regional estimates of COPD prevalence: systematic review and meta-analysis","volume":"5","author":"Adeloye","year":"2015","journal-title":"J. Global Health"},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.21037\/atm.2019.12.40","article-title":"Application of novel nanotechnologies in asthma","volume":"8","author":"da Silva","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib10","article-title":"Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease","volume":"1","author":"Harrison","year":"2019","journal-title":"Respir. Med. X"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.16-0733","article-title":"Severity of pneumonia in under 5-year-old children from developing countries: a multicenter, prospective, observational study","volume":"97","author":"B\u00e9net","year":"2017","journal-title":"Am. Soc. Tropical Med. Hygiene"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(22)00092-3","article-title":"The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions","volume":"10","author":"Dheda","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1179548420982786","article-title":"Spotlight on new antibiotics for the treatment of pneumonia","volume":"14","author":"Russo","year":"2020","journal-title":"Clin. Med. Insights Circulatory, Respir. Pulm. Med."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib14","doi-asserted-by":"crossref","first-page":"a017822","DOI":"10.1101\/cshperspect.a017822","article-title":"Tuberculosis treatment and drug regimens","volume":"5","author":"Sotgiu","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib15","article-title":"Advancements in the management of severe community-acquired pneumonia: a comprehensive narrative review","volume":"15","author":"Davis","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","article-title":"Lung cancer: epidemiology, etiology, and prevention","volume":"32","author":"Dela Cruz","year":"2011","journal-title":"Clin. Chest Med."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1470-2045(19)30329-8","article-title":"5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study","volume":"20","author":"Luo","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11701-022-01512-8","article-title":"Approaches and outcomes of Robotic-Assisted Thoracic Surgery (RATS) for lung cancer: a narrative review","volume":"17","author":"Mattioni","year":"2023","journal-title":"J. Robotic Surgery."},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib20","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1097\/JTO.0000000000000346","article-title":"Intensity-modulated radiotherapy for lung cancer: current status and future developments","volume":"9","author":"Chan","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib21","first-page":"361","article-title":"Lung stereotactic body radiation therapy","volume":"112","author":"Rehman","year":"2015","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4046\/trd.2018.0068","article-title":"Chemotherapy for lung cancer in the era of personalized medicine","volume":"82","author":"Lee","year":"2019","journal-title":"Tuberc. Respir. Dis."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib23","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/j.cllc.2022.02.004","article-title":"Phase II trial of combination nab-paclitaxel and gemcitabine in non\u2013squamous non\u2013small cell lung cancer after progression on platinum and pemetrexed","volume":"23","author":"Ciunci","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.mtbio.2025.101616_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104295","article-title":"The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies","volume":"196","author":"Ferro","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mtbio.2025.101616_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/pharmaceutics12070616","article-title":"Cystic fibrosis: overview of the current development trends and innovative therapeutic strategies","volume":"12","author":"Almughem","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5863\/1551-6776-25.3.192","article-title":"Elexacaftor-tezacaftor-ivacaftor: the first triple-combination cystic fibrosis transmembrane conductance regulator modulating therapy","volume":"25","author":"Ridley","year":"2020","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.mtbio.2025.101616_bib27","doi-asserted-by":"crossref","first-page":"a017863","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib28","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/nop2.357","article-title":"Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care","volume":"6","author":"Lindh","year":"2019","journal-title":"Nursing Open"},{"key":"10.1016\/j.mtbio.2025.101616_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/resp.14147","article-title":"Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand","volume":"26","author":"Blakey","year":"2021","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib31","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coph.2020.11.002","article-title":"Nanotechnology in pulmonary medicine","volume":"56","author":"Doroudian","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12931-015-0223-5","article-title":"Nanotechnology in respiratory medicine","volume":"16","author":"Omlor","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.mtbio.2025.101616_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.sajce.2023.08.009","article-title":"An overview of nanoparticles in drug delivery: properties and applications","volume":"46","author":"Hsu","year":"2023","journal-title":"South Afr. J. Chem. Eng."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.101616_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","article-title":"Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment","volume":"5","author":"Elumalai","year":"2024","journal-title":"Biomed. Technol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157341305774642939","article-title":"Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: approaches experimental evidences and theory","volume":"1","author":"J","year":"2005","journal-title":"Curr. Nanosci."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib39","doi-asserted-by":"crossref","first-page":"eaam6431","DOI":"10.1126\/scirobotics.aam6431","article-title":"Micro\/nanorobots for biomedicine: delivery, surgery, sensing, and detoxification","volume":"2","author":"Li","year":"2017","journal-title":"Sci. Robot."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000512","article-title":"Biomedical micro-\/nanomotors: from overcoming biological barriers to in vivo imaging","volume":"33","author":"Gao","year":"2021","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib41","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/anie.201406096","article-title":"Chemically powered micro- and nanomotors","volume":"54","author":"S\u00e1nchez","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"issue":"21","key":"10.1016\/j.mtbio.2025.101616_bib42","article-title":"Medical micro\/nanorobots in precision medicine","volume":"7","author":"Soto","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fbioe.2018.00170","article-title":"Frontiers of medical micro\/nanorobotics: in vivo applications and commercialization perspectives toward clinical uses","volume":"6","author":"Soto","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-023-01463-z","article-title":"Advances of medical nanorobots for future cancer treatments","volume":"16","author":"Kong","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2025.101616_bib45","article-title":"Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance","volume":"7","author":"Yihan Yao","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"null","key":"10.1016\/j.mtbio.2025.101616_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/NSA.S8199","article-title":"Nanoparticles as biochemical sensors","volume":"3","author":"El-Ansary","year":"2010","journal-title":"Nanotechnol. Sci. Appl."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s40820-023-01261-9","article-title":"Untethered micro\/nanorobots for remote sensing: toward intelligent platform","volume":"16","author":"Wang","year":"2023","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.mtbio.2025.101616_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fchem.2018.00323","article-title":"Spectroscopic studies as a toolbox for biophysical and chemical characterization of lipid-based nanotherapeutics","volume":"323","author":"Fernandes","year":"2018","journal-title":"Front. Chem."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/pharmaceutics12070665","article-title":"Micro\/Nanorobot: a promising targeted drug delivery system","volume":"12","author":"Hu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.101616_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/nano14020131","article-title":"Transport of nanoparticles into plants and their detection methods","volume":"14","author":"Sembada","year":"2024","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1039\/C8NR07769J","article-title":"Applications of nanoparticles in biomedical imaging","volume":"11","author":"Han","year":"2019","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scirobotics.aaq1155","article-title":"Multifunctional biohybrid magnetite microrobots for imaging-guided therapy","volume":"2","author":"Yan","year":"2017","journal-title":"Sci. Robot."},{"key":"10.1016\/j.mtbio.2025.101616_bib53","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102117","article-title":"Nanomaterials in the diagnosis and treatment of ophthalmic diseases","volume":"54","author":"Ma","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.mtbio.2025.101616_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1347312","article-title":"Application of micro\/nanorobot in medicine","volume":"12","author":"Sun","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.mtbio.2025.101616_bib56","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2147\/IJN.S121956","article-title":"The antimicrobial activity of nanoparticles: present situation and prospects for the future","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep18877","article-title":"Potent antibacterial nanoparticles against biofilm and intracellular bacteria","volume":"6","author":"Mu","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101991","article-title":"Micro-\/Nanorobots in antimicrobial applications: recent progress, challenges, and opportunities","volume":"11","author":"Zhang","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2024.1456939","article-title":"Recent advances in surface decoration of nanoparticles in drug delivery","volume":"6","author":"Ly","year":"2024","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.mtbio.2025.101616_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/app112110385","article-title":"A brief review on challenges in design and development of nanorobots for medical applications","volume":"11","author":"Giri","year":"2021","journal-title":"Appl. Sci."},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib61","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1039\/D0EN00570C","article-title":"Environmental and health risks of nanorobots: an early review","volume":"7","author":"Arvidsson","year":"2020","journal-title":"Environ. Sci. Nano"},{"key":"10.1016\/j.mtbio.2025.101616_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/942916","article-title":"Mechanisms of nanoparticle-induced oxidative stress and toxicity","volume":"2013","author":"Manke","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.mtbio.2025.101616_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103010","article-title":"A review of physical, chemical and biological synthesis methods of bimetallic nanoparticles and applications in sensing, water treatment, biomedicine, catalysis and hydrogen storage","volume":"321","author":"Nyabadza","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib64","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1002\/mco2.327","article-title":"Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2020","journal-title":"MedComm"},{"issue":"15","key":"10.1016\/j.mtbio.2025.101616_bib65","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.1021\/acsnano.3c03723","article-title":"Microrobots for biomedicine: unsolved challenges and opportunities for translation","volume":"17","author":"Lee","year":"2023","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib66","doi-asserted-by":"crossref","first-page":"18048","DOI":"10.1021\/acsnano.1c06651","article-title":"Environmentally adaptive shape-morphing microrobots for localized cancer cell treatment","volume":"15","author":"Xin","year":"2021","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib67","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3390\/mi14081607","article-title":"Four-dimensional-printed microrobots and their applications: a review","volume":"14","author":"Darmawan","year":"2023","journal-title":"Micromachines"},{"issue":"9","key":"10.1016\/j.mtbio.2025.101616_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/admt.201900332","article-title":"Indirect 3D and 4D printing of soft robotic microstructures","volume":"4","author":"de Marco","year":"2019","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.mtbio.2025.101616_bib69","series-title":"Emerging Nanotechnologies in Dentistry","first-page":"365","article-title":"Chapter 21 - nanodiagnostics in microbiology and dentistry","author":"Mehta","year":"2012"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1567201819666220331094812","article-title":"DNA nanobots - emerging customized nanomedicine in oncology","volume":"20","author":"Singh","year":"2023","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.mtbio.2025.101616_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/frobt.2021.705454","article-title":"Endorobots for colonoscopy: design challenges and available technologies","volume":"8","author":"Manfredi","year":"2021","journal-title":"Front. Robot. AI"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib72","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1021\/acs.chemrev.0c01234","article-title":"Magnetically driven micro and nanorobots","volume":"121","author":"Zhou","year":"2021","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib73","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1021\/acs.nanolett.9b03051","article-title":"Multifunctional nanorobot system for active therapeutic delivery and synergistic chemo-photothermal therapy","volume":"19","author":"Jin","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.101616_bib74","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/drones7040269","article-title":"A review of swarm robotics in a NutShell","volume":"7","author":"Shahzad","year":"2023","journal-title":"Drones"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib75","first-page":"242","article-title":"Nanomedicine: promising tiny machine for the healthcare in future-a review","volume":"24","author":"Saha","year":"2009","journal-title":"Oman Med. J."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib76","first-page":"55","article-title":"Microbivores: artificial mechanical phagocytes using digest and discharge protocol","volume":"14","author":"Freitas Jr","year":"2005","journal-title":"J. Evol. Technol."},{"issue":"9\u201310","key":"10.1016\/j.mtbio.2025.101616_bib77","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1166\/jnn.2006.413","article-title":"Pharmacytes: an ideal vehicle for targeted drug delivery","volume":"6","author":"Freitas","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1166\/ajrs.2014.1010","article-title":"Nanorobotic applications in medicine: current proposals and designs","volume":"1","author":"Saadeh","year":"2014","journal-title":"Am. J. Robot. Surgery."},{"key":"10.1016\/j.mtbio.2025.101616_bib79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fnins.2018.00153","article-title":"Integration of nanobots into neural circuits as a future therapy for treating neurodegenerative disorders","volume":"12","author":"Saniotis","year":"2018","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib80","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/biomimetics8070553","article-title":"Macrophage-based microrobots for anticancer therapy: recent progress and future perspectives","volume":"8","author":"Nguyen","year":"2023","journal-title":"Biomimetics"},{"key":"10.1016\/j.mtbio.2025.101616_bib81","doi-asserted-by":"crossref","DOI":"10.34133\/2022\/9824057","article-title":"Biohybrid micro- and nanorobots for intelligent drug delivery","volume":"2022","author":"Li","year":"2022","journal-title":"Cyborg Bionic Syst."},{"issue":"9","key":"10.1016\/j.mtbio.2025.101616_bib82","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1021\/acsnano.7b03207","article-title":"Multifunctional bacteria-driven microswimmers for targeted active drug delivery","volume":"11","author":"Park","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101616_bib83","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/bioengineering11040311","article-title":"Bio-hybrid magnetic robots: from bioengineering to targeted therapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Bioengineering"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib84","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1021\/acs.nanolett.6b00262","article-title":"Bacteria-mediated hypoxia-specific delivery of nanoparticles for tumors imaging and therapy","volume":"16","author":"Luo","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.101616_bib85","doi-asserted-by":"crossref","unstructured":"Akolpoglu, M.B., Alapan, Y., Dogan, N.O., Baltaci, S.F., Yasa, O., Aybar Tural, G., and Sitti, M., Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery. Sci. Adv.. 8(28): p. eabo6163, 10.1126\/sciadv.abo6163.","DOI":"10.1126\/sciadv.abo6163"},{"issue":"null","key":"10.1016\/j.mtbio.2025.101616_bib86","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.2147\/IJN.S338272","article-title":"Innovative approaches of engineering tumor-targeting bacteria with different therapeutic payloads to fight cancer: a smart strategy of disease management","volume":"16","author":"Allemailem","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"17","key":"10.1016\/j.mtbio.2025.101616_bib87","doi-asserted-by":"crossref","first-page":"15251","DOI":"10.1021\/acsami.9b00495","article-title":"Macrophages-mediated delivery of small gold nanorods for tumor hypoxia photoacoustic imaging and enhanced photothermal therapy","volume":"11","author":"An","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.101616_bib88","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib89","article-title":"Macrophage-mediated cancer drug delivery","volume":"11\u201312","author":"Wang","year":"2021","journal-title":"Mater. Today Sustain."},{"issue":"34","key":"10.1016\/j.mtbio.2025.101616_bib90","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1073\/pnas.0505481102","article-title":"Microoxen: microorganisms to move microscale loads","volume":"102","author":"Weibel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib91","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1021\/acsnano.2c00833","article-title":"Magnetically actuated biohybrid microswimmers for precise photothermal muscle contraction","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib92","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1021\/acsami.1c16859","article-title":"Magnetic biohybrid microrobot multimers based on chlorella cells for enhanced targeted drug delivery","volume":"14","author":"Gong","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib93","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nnano.2016.137","article-title":"Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions","volume":"11","author":"Felfoul","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib94","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/bit.25007","article-title":"Motility analysis of bacteria-based microrobot (bacteriobot) using chemical gradient microchamber","volume":"111","author":"Park","year":"2014","journal-title":"Biotechnol. Bioeng."},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib95","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41563-022-01360-9","article-title":"Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia","volume":"21","author":"Zhang","year":"2022","journal-title":"Nat. Mater."},{"issue":"20","key":"10.1016\/j.mtbio.2025.101616_bib96","article-title":"Biodegradable microalgae-based carriers for targeted delivery and imaging-guided therapy toward lung metastasis of breast cancer","volume":"16","author":"Zhong","year":"2020","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/acsnano.7b06398","article-title":"Sperm-hybrid micromotor for targeted drug delivery","volume":"12","author":"Xu","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib98","article-title":"Hybrid-actuating macrophage-based microrobots for active cancer therapy","volume":"6","author":"Han","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2025.101616_bib99","series-title":"Progress in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.pmch.2022.04.001","article-title":"Chapter Two - advances in the design of new types of inhaled medicines","author":"Czechtizky","year":"2022"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.10-0166","article-title":"Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source","volume":"139","author":"Fujitani","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.mtbio.2025.101616_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/biomedicines12010123","article-title":"Extracellular vesicles and exosomes: novel insights and perspectives on lung cancer from early detection to targeted treatment","volume":"12","author":"Rahimian","year":"2024","journal-title":"Biomedicines"},{"issue":"3, Supplement","key":"10.1016\/j.mtbio.2025.101616_bib102","doi-asserted-by":"crossref","first-page":"368S","DOI":"10.1378\/chest.07-1391","article-title":"Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Kvale","year":"2007","journal-title":"Chest"},{"issue":"31","key":"10.1016\/j.mtbio.2025.101616_bib103","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/D0TB00649A","article-title":"Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy","volume":"8","author":"Zhou","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2025.101616_bib104","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.2147\/IJN.S110146","article-title":"Nanomedicine engulfed by macrophages for targeted tumor therapy","volume":"11","author":"Li","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib105","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib106","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820936161","article-title":"Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology","volume":"18","author":"Yan","year":"2020","journal-title":"Dose Response"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib107","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1080\/10717544.2022.2089296","article-title":"Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems","volume":"29","author":"Bajracharya","year":"2022","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib108","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.101616_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121742","article-title":"Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery","volume":"17","author":"Du","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib110","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/pharmaceutics14122783","article-title":"Injectable nano drug delivery systems for the treatment of breast cancer","volume":"14","author":"Kafle","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.101616_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater. Res."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib112","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","article-title":"Albumin-bound paclitaxel: a next-generation taxane","volume":"7","author":"Gradishar","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib113","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/14737140.2014.881719","article-title":"nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer","volume":"14","author":"Hirsh","year":"2014","journal-title":"Expet Rev. Anticancer Ther."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib114","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10637-012-9921-8","article-title":"First-in-human phase 1\/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies","volume":"31","author":"Weiss","year":"2013","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.mtbio.2025.101616_bib115","article-title":"Camptothecin loaded nano-delivery systems in the cancer therapeutic domains: a critical examination of the literature","volume":"79","author":"Alshammari","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"15_suppl","key":"10.1016\/j.mtbio.2025.101616_bib116","doi-asserted-by":"crossref","first-page":"TPS9081","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS9081","article-title":"RESILIENT part II: an open-label, randomized, phase III study of liposomal irinotecan injection in patients with small-cell lung cancer who have progressed with platinum-based first-line therapy","volume":"38","author":"Paz-Ares","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.mtbio.2025.101616_bib117","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib118","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/pharmaceutics12060510","article-title":"Nanotechnology as a platform for the development of injectable parenteral formulations: a comprehensive review of the know-hows and state of the art","volume":"12","author":"Shetab Boushehri","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib119","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.mtbio.2025.101616_bib120","article-title":"Nanotherapeutics for pulmonary drug delivery: an emerging approach to overcome respiratory diseases","volume":"81","author":"Kole","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib121","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/pharmaceutics12111025","article-title":"Pulmonary delivery of biological drugs","volume":"12","author":"Liang","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.101616_bib122","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2019.10.035","article-title":"Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy","volume":"314","author":"He","year":"2019","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib123","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/nnm.09.8","article-title":"Nanomedicine for the management of lung and blood diseases","volume":"4","author":"Buxton","year":"2009","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib124","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jamp.2016.1297","article-title":"The history of therapeutic aerosols: a chronological review","volume":"30","author":"Stein","year":"2017","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib125","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib126","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","article-title":"Polymeric nanoparticles for pulmonary protein and DNA delivery","volume":"10","author":"Menon","year":"2014","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib127","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2010.02.006","article-title":"Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers","volume":"144","author":"Patlolla","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mtbio.2025.101616_bib129","article-title":"Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique","volume":"91","author":"Wang","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.mtbio.2025.101616_bib130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/pharmaceutics12030206","article-title":"Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment","volume":"12","author":"Parvathaneni","year":"2020","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib131","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/1078-0432.CCR-06-1480","article-title":"Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung","volume":"13","author":"Wittgen","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib132","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/jam.1999.12.275","article-title":"Intrapulmonary distribution of deposited particles","volume":"12","author":"Brand","year":"1999","journal-title":"J. Aerosol Med."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib133","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib134","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/17425247.4.6.607","article-title":"The nanoscale in pulmonary delivery. Part 2: formulation platforms","volume":"4","author":"Rogueda","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2025.101616_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.12.040","article-title":"3rd, Influence of particle size on regional lung deposition--what evidence is there?","volume":"406","author":"Carvalho","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib136","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drudis.2019.09.023","article-title":"Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery","volume":"25","author":"Liu","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib137","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1165\/rcmb.2020-0306TR","article-title":"Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases","volume":"64","author":"Deng","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib138","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12989-018-0282-0","article-title":"Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives","volume":"15","author":"Poh","year":"2018","journal-title":"Part. Fibre Toxicol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib139","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.nano.2015.11.002","article-title":"Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells","volume":"12","author":"Fromen","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2013.08.028","article-title":"Uptake and transport of B12-conjugated nanoparticles in airway epithelium","volume":"172","author":"Fowler","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mtbio.2025.101616_bib141","article-title":"Nanostructures for drug delivery in respiratory diseases therapeutics: revision of current trends and its comparative analysis","volume":"70","author":"Ibarra-S\u00e1nchez","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.mtbio.2025.101616_bib142","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.101616_bib143","article-title":"Pulmonary inhalation for disease treatment: basic research and clinical translations","volume":"25","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2025.101616_bib144","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","article-title":"Inhaled formulations and pulmonary drug delivery systems for respiratory infections","volume":"85","author":"Zhou","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003941","article-title":"Multiscale Co-reconstruction of lung architectures and inhalable materials spatial distribution","volume":"8","author":"Sun","year":"2021","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib146","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1152\/jappl.1998.85.2.379","article-title":"Recent advances in pulmonary drug delivery using large, porous inhaled particles","volume":"85","author":"Edwards","year":"1998","journal-title":"J. Appl. Physiol."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib147","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/acs.molpharmaceut.1c00125","article-title":"Inhalable porous microspheres loaded with metformin and docosahexaenoic acid suppress tumor metastasis by modulating premetastatic niche","volume":"18","author":"Chen","year":"2021","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib148","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2125.2003.01893.x","article-title":"Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.mtbio.2025.101616_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121551","article-title":"Micro\/nanorobots for precise drug delivery via targeted transport and triggered release: a review","volume":"616","author":"Xu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.apmt.2019.07.017","article-title":"Hollow mesoporous carbon@Pt Janus nanomotors with dual response of H2O2 and near-infrared light for active cargo delivery","volume":"17","author":"Xing","year":"2019","journal-title":"Appl. Mater. Today"},{"issue":"24","key":"10.1016\/j.mtbio.2025.101616_bib151","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn6157","article-title":"Biohybrid microrobots locally and actively deliver drug-loaded nanoparticles to inhibit the progression of lung metastasis","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib152","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41467-025-56032-4","article-title":"Inhalable biohybrid microrobots: a non-invasive approach for lung treatment","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib153","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib154","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/acsomega.2c04078","article-title":"Advances in lung cancer treatment using nanomedicines","volume":"8","author":"Sharma","year":"2023","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ajhp\/59.7.611","article-title":"Lung cancer: a review","volume":"59","author":"Cersosimo","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib156","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.mtbio.2025.101616_bib157","series-title":"Circulating Tumor DNA in Non\u2013small-cell Lung Cancer: A Primer for the Clinician","first-page":"1","author":"Singh","year":"2017"},{"issue":"9","key":"10.1016\/j.mtbio.2025.101616_bib158","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/biology10090864","article-title":"Next generation sequencing technology in lung cancer diagnosis","volume":"10","author":"Cainap","year":"2021","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib159","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4143\/crt.2022.078","article-title":"Challenges in the use of targeted therapies in non-small cell lung cancer","volume":"54","author":"Rivera-Concepcion","year":"2022","journal-title":"Cancer Res. Treatment"},{"key":"10.1016\/j.mtbio.2025.101616_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1177151","article-title":"Advances in nanomaterial-based targeted drug delivery systems","volume":"11","author":"Cheng","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib161","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2009.07.023","article-title":"Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells","volume":"382","author":"Tahara","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib162","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib163","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2007.12.041","article-title":"Histological examination of PLGA nanospheres for intratracheal drug administration","volume":"356","author":"Hara","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2004.03.008","article-title":"PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium","volume":"58","author":"Bivas-Benita","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib165","article-title":"DOE supported optimization of biodegradable polymeric nanoparticles based dry powder inhaler for targeted delivery of afatinib in non-small cell lung cancer","volume":"84","author":"Vanza","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib166","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11095-020-02790-3","article-title":"Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer","volume":"37","author":"Shukla","year":"2020","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib167","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.apsb.2019.10.011","article-title":"Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib168","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1021\/acsnano.3c13039","article-title":"Antiangiogenic therapeutic mRNA delivery using lung-selective polymeric nanomedicine for lung cancer treatment","volume":"18","author":"Le","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib169","doi-asserted-by":"crossref","first-page":"rqac007","DOI":"10.1093\/rpsppr\/rqac007","article-title":"Formulation of resveratrol into PGA-co-PDL nanoparticles increases its cytotoxic potency against lung cancer cells","volume":"2","author":"Muller","year":"2023","journal-title":"RPS Pharmacy Pharmacology Rep."},{"key":"10.1016\/j.mtbio.2025.101616_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122587","article-title":"RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy","volume":"633","author":"Yadav","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111623","article-title":"Integrin \u03b1v\u03b23-targeted liposomal drug delivery system for enhanced lung cancer therapy","volume":"201","author":"Fu","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib172","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.apsb.2018.03.004","article-title":"Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib173","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/ph14030221","article-title":"Lipidated peptidomimetic ligand-functionalized HER2 targeted liposome as nano-carrier designed for doxorubicin delivery in cancer therapy","volume":"14","author":"Naik","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib174","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/tx5001128","article-title":"Enhanced toxicity of cisplatin with chemosensitizer phenethyl isothiocyanate toward non-small cell lung cancer cells when delivered in liposomal nanoparticles","volume":"27","author":"Yang","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s13346-018-0526-4","article-title":"Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment","volume":"9","author":"Asmawi","year":"2019","journal-title":"Drug Deliv. Translational Res."},{"key":"10.1016\/j.mtbio.2025.101616_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109493","article-title":"Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor\u2014afatinib: in vitro and in vivo evaluation","volume":"120","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib177","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/nano10061076","article-title":"Superparamagnetic iron oxide nanoparticles modified with silica layers as potential agents for lung cancer treatment","volume":"10","author":"Reczy\u0144ska","year":"2020","journal-title":"Nanomaterials"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib178","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1021\/acsbiomaterials.0c00287","article-title":"Enhancing targeted cancer treatment by combining hyperthermia and radiotherapy using Mn\u2013Zn ferrite magnetic nanoparticles","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"19","key":"10.1016\/j.mtbio.2025.101616_bib179","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1039\/D1BM01124C","article-title":"Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer","volume":"9","author":"Peng","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114146","article-title":"Cisplatin-loaded gold nanoshells mediate chemo-photothermal therapy against primary and distal lung cancers growth","volume":"158","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2025.101616_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116845","article-title":"Apoptotic efficiency of Dicoma anomala biosynthesized silver nanoparticles against A549 lung cancer cells","volume":"176","author":"Chota","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31212","article-title":"Functionalized graphene oxide NPs as a nanocarrier for drug delivery system in quercetin\/lurbinectedin as dual sensitive therapeutics for A549 lung cancer treatment","volume":"10","author":"Liao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.mtbio.2025.101616_bib183","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.msec.2016.05.013","article-title":"Effects of transferrin conjugated multi-walled carbon nanotubes in lung cancer delivery","volume":"67","author":"Singh","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.mtbio.2025.101616_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.mssp.2023.107797","article-title":"ZnO quantum dots @ nitrogen and sulfur Co-doped porous carbon nanosheets for the detection of lung cancer biomarkers in exhaled breath","volume":"167","author":"Nithyakalyani","year":"2023","journal-title":"Mater. Sci. Semicond. Process."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib185","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1038\/s41598-021-87010-7","article-title":"Magnetic tri-bead microrobot assisted near-infrared triggered combined photothermal and chemotherapy of cancer cells","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib186","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nbt.4071","article-title":"A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo","volume":"36","author":"Li","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib187","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1039\/C7NR09692E","article-title":"Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures","volume":"10","author":"Xie","year":"2018","journal-title":"Nanoscale"},{"issue":"19","key":"10.1016\/j.mtbio.2025.101616_bib188","article-title":"Metal-coordinated adsorption of nanoparticles to macrophages for targeted cancer therapy","volume":"33","author":"Zhu","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2023.111154","article-title":"Delivery of magnetic nanoparticles to lung cancer cells via polarized macrophages: a riveting tale of a bio-inspired phenomenon","volume":"179","author":"Agnihotri","year":"2023","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mtbio.2025.101616_bib190","first-page":"422","article-title":"Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles","volume":"34","author":"Yaman","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118237","article-title":"Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer","volume":"268","author":"Zhu","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib192","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/00914037.2022.2163639","article-title":"Evaluation of liposomes for targeted drug delivery in lung cancer treatment","volume":"73","author":"Bhuimali","year":"2024","journal-title":"International Journal of Polymeric Materials and Polymeric Biomaterials"},{"key":"10.1016\/j.mtbio.2025.101616_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.jciso.2023.100095","article-title":"Micro and nano-carriers-based pulmonary drug delivery system: their current updates, challenges, and limitations \u2013 a review","volume":"12","author":"Kumar","year":"2023","journal-title":"JCIS Open"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib194","article-title":"The treatment of breast cancer using liposome technology","volume":"2012","author":"Brown","year":"2012","journal-title":"J. Drug Deliv."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0005-2736(01)00392-3","article-title":"Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides","volume":"1515","author":"Fillion","year":"2001","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembranes."},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib196","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib197","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib198","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2022.03.028","article-title":"Lung targeted liposomes for treating ARDS","volume":"346","author":"Arber Raviv","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mtbio.2025.101616_bib199","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.2147\/IJN.S450534","article-title":"EGFR targeting of liposomal doxorubicin improves recognition and suppression of non-small cell lung cancer","volume":"19","author":"Moles","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib200","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1208\/s12248-017-0057-9","article-title":"Aptamer-conjugated chitosan-anchored liposomal complexes for targeted delivery of erlotinib to EGFR-mutated lung cancer cells","volume":"19","author":"Li","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.mtbio.2025.101616_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126599","article-title":"CD44 tagged hyaluronic acid - chitosan liposome carrier for the delivery of berberine and doxorubicin into lung cancer cells","volume":"253","author":"Uma Maheswari","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib202","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jmmm.2005.02.038","article-title":"Magnetic targeting of aerosol particles for cancer therapy","volume":"293","author":"Ally","year":"2005","journal-title":"J. Magn. Magn. Mater."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib203","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.actbio.2012.04.029","article-title":"Folate\u2013PEG\u2013superparamagnetic iron oxide nanoparticles for lung cancer imaging","volume":"8","author":"Yoo","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.101616_bib204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.freeradbiomed.2018.10.429","article-title":"Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy","volume":"130","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"17","key":"10.1016\/j.mtbio.2025.101616_bib205","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1021\/acsnano.3c08335","article-title":"Superparamagnetic iron oxide nanoparticles reprogram the tumor microenvironment and reduce lung cancer regrowth after crizotinib treatment","volume":"18","author":"Horvat","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101616_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114065","article-title":"Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems","volume":"157","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib207","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1109\/TNB.2016.2621730","article-title":"Nanoparticles for siRNA-based gene silencing in tumor therapy","volume":"15","author":"Babu","year":"2016","journal-title":"IEEE Trans. NanoBioscience"},{"key":"10.1016\/j.mtbio.2025.101616_bib208","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2147\/IJN.S398254","article-title":"Albumin-modified gold nanoparticles as novel radiosensitizers for enhancing lung cancer radiotherapy","volume":"18","author":"Chen","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.101616_bib209","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/jfb14080407","article-title":"Anti-tumor activity of novel nimotuzumab-functionalized gold nanoparticles as a potential immunotherapeutic agent against skin and lung cancers","volume":"14","author":"Anisuzzman","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.mtbio.2025.101616_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1018759","article-title":"Use of gold nanoparticle-silibinin conjugates: a novel approach against lung cancer cells","volume":"10","author":"Ravi","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.mtbio.2025.101616_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.149039","article-title":"Clinically approved carbon nanoparticles for enhanced photothermal-immunotherapy toward cancer metastasis","volume":"482","author":"Zhao","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2025.101616_bib212","article-title":"Use of multi-walled carbon nanotubes (MWCNTs) stabilized in Arabic gum colloidal solution to induce genotoxicity and apoptosis of human breast and lung cancer cell lines","volume":"1229637","author":"Al-zharani","year":"2023","journal-title":"Front. Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib213","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1586\/ers.11.72","article-title":"Carbon nanotubes as delivery systems for respiratory disease: do the dangers outweigh the potential benefits?","volume":"5","author":"Bonner","year":"2011","journal-title":"Expet Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib214","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/17435390.2020.1851418","article-title":"Inhaled multi-walled carbon nanotubes differently modulate global gene and protein expression in rat lungs","volume":"15","author":"Seidel","year":"2021","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.mtbio.2025.101616_bib215","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.2147\/IJN.S263238","article-title":"The applications of carbon nanotubes in the diagnosis and treatment of lung cancer: a critical review","volume":"15","author":"Sheikhpour","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"16","key":"10.1016\/j.mtbio.2025.101616_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202001256","article-title":"High-yield production of biohybrid microalgae for on-demand cargo delivery","volume":"7","author":"Akolpoglu","year":"2020","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib217","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/cancers12123773","article-title":"Cancer immunotherapy and application of nanoparticles in cancers immunotherapy as the delivery of immunotherapeutic agents and as the immunomodulators","volume":"12","author":"Debele","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib218","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn5062029","article-title":"Nanoparticle-based immunotherapy for cancer","volume":"9","author":"Shao","year":"2015","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib219","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib220","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1038\/s41467-022-31926-9","article-title":"Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment","volume":"13","author":"Reda","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib221","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007557","article-title":"Nanoparticle-mediated delivery of inhaled immunotherapeutics for treating lung metastasis","volume":"33","author":"Jin","year":"2021","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib222","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"J. ImmunoTherapy Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib223","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12645-022-00116-z","article-title":"Delivery of CXCL9\/10\/11 plasmid DNAs promotes the tumor-infiltration of T cells and synergizes with PD1 antibody for treating lung cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Cancer Nanotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib224","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.idc.2009.06.008","article-title":"Pharmacokinetics and pharmacodynamics of antibacterial agents","volume":"23","author":"Levison","year":"2009","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib225","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1021\/nn5042625","article-title":"Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria","volume":"8","author":"Li","year":"2014","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12951-022-01573-9","article-title":"Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies","volume":"20","author":"Chakraborty","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.101616_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106515","article-title":"Nanoparticles-based therapeutics for the management of bacterial infections: a special emphasis on FDA approved products and clinical trials","volume":"188","author":"Aflakian","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib228","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00253-011-3213-7","article-title":"Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity","volume":"90","author":"Foster","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102120","article-title":"Biosynthesized copper oxide nanoparticles (CuO NPs) enhances the anti-biofilm efficacy against K. pneumoniae and S. aureus","volume":"34","author":"Bai","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"issue":"52","key":"10.1016\/j.mtbio.2025.101616_bib230","article-title":"Antibacterial action of nanoparticles by lethal stretching of bacterial cell membranes","volume":"32","author":"Linklater","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib231","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fphar.2019.01153","article-title":"Nanoparticles in the treatment of infections caused by multidrug-resistant organisms","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib232","first-page":"993","article-title":"Antimicrobial therapy of community-acquired pneumonia","volume":"18","author":"File","year":"2004","journal-title":"Infect. Dis. Clin."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib233","doi-asserted-by":"crossref","first-page":"692","DOI":"10.62110\/sciencein.jmc.2024.692","article-title":"Ceftobiprole medocaril (Zevtera) \u2013 FDA approved antibiotic for three infections including methicillin-resistant Staphylococcus aureus","volume":"4","author":"Singh","year":"2024","journal-title":"J. Mol. Chem."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib234","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4140\/TCP.n.2020.349","article-title":"A review of newly approved antibiotic treatment for community-acquired bacterial pneumonia: lefamulin","volume":"35","author":"Wang","year":"2020","journal-title":"Senior Care Pharmacist"},{"key":"10.1016\/j.mtbio.2025.101616_bib235","first-page":"Doc02","article-title":"Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations","volume":"9","author":"Duwe","year":"2021","journal-title":"GMS Infectious Diseases"},{"issue":"36","key":"10.1016\/j.mtbio.2025.101616_bib236","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-valent pneumococcal conjugate vaccine among U.S. Adults: recommendations of the advisory committee on immunization Practices \u2014 United States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.mtbio.2025.101616_bib237","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415738","article-title":"Nanomaterials for delivering antibiotics in the therapy of pneumonia","volume":"23","author":"Tang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib238","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s13346-021-00954-1","article-title":"Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections","volume":"11","author":"Huang","year":"2021","journal-title":"Drug Deliv. Translational Res."},{"key":"10.1016\/j.mtbio.2025.101616_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124208","article-title":"Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication","volume":"658","author":"Wang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/magnetochemistry6020025","article-title":"Successes and challenges: inhaled treatment approaches using magnetic nanoparticles in cystic fibrosis","volume":"6","author":"Tan","year":"2020","journal-title":"Magnetochemistry"},{"key":"10.1016\/j.mtbio.2025.101616_bib241","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics15010003","article-title":"Inhalable polymeric nanoparticles for pulmonary delivery of antimicrobial peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo","volume":"15","author":"Cresti","year":"2023","journal-title":"Pharmaceutics"},{"issue":"34","key":"10.1016\/j.mtbio.2025.101616_bib242","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1039\/D3TB02970K","article-title":"Inhalable mucin-permeable nanomicelles deliver antibiotics for effective treatment of chronic pneumonia","volume":"12","author":"Jiang","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"28","key":"10.1016\/j.mtbio.2025.101616_bib243","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1021\/acs.nanolett.4c02318","article-title":"Inhalable polymeric microparticles for phage and photothermal synergistic therapy of methicillin-resistant Staphylococcus aureus pneumonia","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.101616_bib244","article-title":"Inhalable vancomycin-loaded lactose microparticles for treatment of MRSA pneumonia","volume":"80","author":"Abdelaziz","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"25","key":"10.1016\/j.mtbio.2025.101616_bib245","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202112145","article-title":"Inhalable MOF-derived nanoparticles for sonodynamic therapy of bacterial pneumonia","volume":"32","author":"Pan","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib246","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jconrel.2024.09.036","article-title":"An inhalable nanoparticle enabling virulence factor elimination and antibiotics delivery for pneumococcal pneumonia therapy","volume":"375","author":"Dong","year":"2024","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib247","doi-asserted-by":"crossref","first-page":"14377","DOI":"10.1021\/acsnano.9b07836","article-title":"Molecular nanomachines disrupt bacterial cell wall, increasing sensitivity of extensively drug-resistant Klebsiella pneumoniae to meropenem","volume":"13","author":"Galbadage","year":"2019","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib248","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1208\/s12249-017-0945-4","article-title":"Inhalable levofloxacin liposomes complemented with lysozyme for treatment of pulmonary infection in rats: effective antimicrobial and antibiofilm strategy","volume":"19","author":"Gupta","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.mtbio.2025.101616_bib249","article-title":"Investigating the potential of endolysin loaded chitosan nanoparticles in the treatment of pneumococcal pneumonia","volume":"61","author":"Gondil","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.mtbio.2025.101616_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213621","article-title":"Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury","volume":"154","author":"Muhammad","year":"2023","journal-title":"Biomater. Adv."},{"issue":"41","key":"10.1016\/j.mtbio.2025.101616_bib251","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1039\/D2NR02026B","article-title":"An inflammation-targeted nanoparticle with bacteria forced release of polymyxin B for pneumonia therapy","volume":"14","author":"Zhang","year":"2022","journal-title":"Nanoscale"},{"issue":"16","key":"10.1016\/j.mtbio.2025.101616_bib252","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1039\/D1BM00924A","article-title":"Targeted delivery of dexamethasone in acute pneumonia","volume":"9","author":"Ma","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113823","article-title":"Biocompatible formulation of a hydrophobic antimicrobial peptide L30 through nanotechnology principles and its potential role in mouse pneumonia model infected with Staphylococcus aureus","volume":"236","author":"Li","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.mtbio.2025.101616_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.155753","article-title":"Enhancing safe and effective treatment of carbapenem-resistant Klebsiella pneumoniae with polymyxin B-loaded dendritic nanoparticles","volume":"498","author":"Zhong","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2025.101616_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2022.102640","article-title":"Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model","volume":"48","author":"Liu","year":"2023","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib256","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/pharmaceutics16030407","article-title":"Nanomedicine for the treatment of viral diseases: smaller solution to bigger problems","volume":"16","author":"Ghorai","year":"2024","journal-title":"Pharmaceutics"},{"issue":"38","key":"10.1016\/j.mtbio.2025.101616_bib257","doi-asserted-by":"crossref","first-page":"50442","DOI":"10.1021\/acsami.4c11525","article-title":"Sonication-assisted self-assembled resveratrol nanoparticles with enhanced antiviral and anti-inflammatory activity against respiratory syncytial virus-induced pneumonia","volume":"16","author":"Chang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.101616_bib258","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403934","article-title":"Simultaneously controlling inflammation and infection by smart nanomedicine responding to the inflammatory microenvironment","author":"Lv","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib259","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2008.11.027","article-title":"One-step preparation of rifampicin\/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis","volume":"135","author":"Ohashi","year":"2009","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tube.2003.07.001","article-title":"Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis","volume":"83","author":"Pandey","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.mtbio.2025.101616_bib261","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcis.2022.05.121","article-title":"Mucus-permeable polymyxin B-hyaluronic acid\/poly (lactic-co-glycolic acid) nanoparticle platform for the nebulized treatment of lung infections","volume":"624","author":"Wu","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.102125","article-title":"PLGA nanocapsules improve the delivery of clarithromycin to kill intracellular Staphylococcus aureus and Mycobacterium abscessus","volume":"24","author":"Anversa Dimer","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib263","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/acs.biomac.8b01829","article-title":"Poly(lactide-co-glycolide) nanoparticles for prolonged therapeutic efficacy of esculentin-1a-derived antimicrobial peptides against Pseudomonas aeruginosa lung infection: in vitro and in vivo studies","volume":"20","author":"Casciaro","year":"2019","journal-title":"Biomacromolecules"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib264","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261720","article-title":"Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections","volume":"16","author":"Sabuj","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2025.101616_bib265","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib266","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/03639045.2018.1513025","article-title":"Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies","volume":"45","author":"Viswanathan","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib267","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkg317","article-title":"Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats","volume":"52","author":"Marier","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"13","key":"10.1016\/j.mtbio.2025.101616_bib268","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s40265-020-01359-z","article-title":"Inhaled liposomal antimicrobial delivery in lung infections","volume":"80","author":"Bassetti","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib269","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s13346-021-01011-7","article-title":"Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals","volume":"11","author":"Thiyagarajan","year":"2021","journal-title":"Drug Deliv. Translational Res."},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib270","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/antibiotics12101510","article-title":"Development of bedaquiline-loaded SNEDDS using quality by design (QbD) approach to improve biopharmaceutical attributes for the management of multidrug-resistant tuberculosis (MDR-TB)","volume":"12","author":"Jahan","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib271","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib272","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/IJN.S218966","article-title":"Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections","volume":"15","author":"Falciani","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.mtbio.2025.101616_bib273","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.7b00169","article-title":"Microencapsulated solid lipid nanoparticles as a hybrid platform for pulmonary antibiotic delivery","volume":"14","author":"Gaspar","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124309","article-title":"Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment","volume":"660","author":"Paul","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017642","article-title":"Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases","volume":"6","author":"Ulery","year":"2011","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.mtbio.2025.101616_bib276","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1016\/j.biomaterials.2014.04.092","article-title":"X-ray CT and pneumonia inhibition properties of gold\u2013silver nanoparticles for targeting MRSA induced pneumonia","volume":"35","author":"Huo","year":"2014","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib277","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10837450.2020.1852570","article-title":"Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide","volume":"26","author":"Changsan","year":"2021","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib278","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/CVI.00263-10","article-title":"Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen A protects mice against nasopharyngeal colonization by Streptococcus pneumoniae","volume":"18","author":"Xu","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib279","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","article-title":"Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease","volume":"79","author":"Shirley","year":"2019","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.mtbio.2025.101616_bib280","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102117","article-title":"Nano-in-Microparticles for aerosol delivery of antibiotic-loaded, fucose-derivatized, and macrophage-targeted liposomes to combat mycobacterial infections: in vitro deposition, pulmonary barrier interactions, and targeted delivery","volume":"11","author":"Huck","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100084","article-title":"Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: in vitro lung deposition and efficacy studies","volume":"3","author":"Puri","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discovery"},{"key":"10.1016\/j.mtbio.2025.101616_bib282","article-title":"Inhalable linezolid loaded PLGA nanoparticles for treatment of tuberculosis: design, development and in vitro evaluation","volume":"60","author":"Shah","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib283","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13205-023-03901-8","article-title":"Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications","volume":"14","author":"Dhayalan","year":"2024","journal-title":"3 Biotech"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib284","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12951-023-01971-7","article-title":"Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects","volume":"21","author":"Wan","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib285","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/polym14061082","article-title":"Novel thymoquinone nanoparticles using poly(ester amide) based on L-arginine-targeting pulmonary drug delivery","volume":"14","author":"Dahmash","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.mtbio.2025.101616_bib286","article-title":"Nasal delivery of hesperidin\/chitosan nanoparticles suppresses cytokine storm syndrome in a mouse model of acute lung injury","volume":"11","author":"Jin","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib287","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41565-022-01174-5","article-title":"Nanotechnology-based strategies against SARS-CoV-2 variants","volume":"17","author":"Huang","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib288","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/acsptsci.0c00179","article-title":"Clinically approved antiviral drug in an orally administrable nanoparticle for COVID-19","volume":"3","author":"Surnar","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"13","key":"10.1016\/j.mtbio.2025.101616_bib289","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003556","article-title":"Antiviral and anti-inflammatory treatment with multifunctional alveolar macrophage-like nanoparticles in a surrogate mouse model of COVID-19","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib290","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nm0397-272","article-title":"Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance","volume":"3","author":"Martin","year":"1997","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib291","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib292","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Int. Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib293","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113731","article-title":"Magnetically controlled nanorobots induced oriented and rapid clearance of the cytokine storm for acute lung injury therapy","volume":"234","author":"Chen","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"20","key":"10.1016\/j.mtbio.2025.101616_bib294","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1021\/acs.nanolett.4c01222","article-title":"Nebulized inhalation of peptide-modified DNA origami to alleviate acute lung injury","volume":"24","author":"Wang","year":"2024","journal-title":"Nano Lett."},{"issue":"20","key":"10.1016\/j.mtbio.2025.101616_bib295","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202100257","article-title":"An antibacterial nanorobotic approach for the specific targeting and removal of multiple drug-resistant Staphylococcus aureus","volume":"17","author":"Batool","year":"2021","journal-title":"Small"},{"issue":"20","key":"10.1016\/j.mtbio.2025.101616_bib296","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211626","article-title":"Chemotaxis-guided self-propelled macrophage motor for targeted treatment of acute pneumonia","volume":"35","author":"Yue","year":"2023","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib297","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101616_bib298","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijbiomac.2022.01.194","article-title":"Improvement of pneumonia by curcumin-loaded bionanosystems based on platycodon grandiflorum polysaccharides via calming cytokine storm","volume":"202","author":"Li","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2025.101616_bib299","article-title":"Plasmonic-magnetic nanorobots for SARS-CoV-2 RNA detection through electronic readout","volume":"27","author":"Kim","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.mtbio.2025.101616_bib300","article-title":"Collective behavior of magnetic microrobots through immuno-sandwich assay: on-the-fly COVID-19 sensing","volume":"26","author":"Mayorga-Martinez","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.mtbio.2025.101616_bib301","article-title":"Versatile nanorobot hand biosensor for specific capture and ultrasensitive quantification of viral nanoparticles","volume":"16","author":"Li","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2025.101616_bib302","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2014.10.004","article-title":"Pulmonary administration of Am80 regenerates collapsed alveoli","volume":"196","author":"Sakai","year":"2014","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib303","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/ph16060838","article-title":"Intracellular drug delivery process of Am80-encapsulated lipid nanoparticles aiming for alveolar regeneration","volume":"16","author":"Akita","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib304","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ccm.2020.05.006","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: benefits and risks","volume":"41","author":"Mkorombindo","year":"2020","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1059343","article-title":"Recent advances in nanoparticle applications in respiratory disorders: a review","volume":"14","author":"Taghavizadeh Yazdi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mtbio.2025.101616_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122946","article-title":"Hyaluronic acid-conjugated liposomes loaded with dexamethasone: a promising approach for the treatment of inflammatory diseases","volume":"639","author":"Bohne Japiassu","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib307","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/pharmaceutics15061772","article-title":"Use of poly lactic-co-glycolic acid nano and micro particles in the delivery of drugs modulating different phases of inflammation","volume":"15","author":"Puricelli","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib308","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ph3030725","article-title":"Theophylline","volume":"3","author":"Barnes","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mtbio.2025.101616_bib309","article-title":"Development and characterization of PLA nanoparticles for pulmonary drug delivery: Co-encapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug","volume":"53","author":"Buhecha","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib310","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.2011.04455.x","article-title":"Role of increased CD8\/CD28null T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease","volume":"166","author":"Hodge","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"11\u201312","key":"10.1016\/j.mtbio.2025.101616_bib311","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10715762.2019.1696965","article-title":"The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD","volume":"54","author":"Chikuma","year":"2020","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.mtbio.2025.101616_bib312","article-title":"Curcumin-loaded mPEG-PLGA nanoparticles attenuates the apoptosis and corticosteroid resistance induced by cigarette smoke extract","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib313","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.nano.2017.08.001","article-title":"Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation","volume":"13","author":"Frede","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib314","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/pharmaceutics15041248","article-title":"Sustained-release powders based on polymer particles for pulmonary delivery of beclomethasone dipropionate in the treatment of lung inflammation","volume":"15","author":"Craparo","year":"2023","journal-title":"Pharmaceutics"},{"issue":"32","key":"10.1016\/j.mtbio.2025.101616_bib315","doi-asserted-by":"crossref","first-page":"E6632","DOI":"10.1073\/pnas.1705508114","article-title":"Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery","volume":"114","author":"Jurcisek","year":"2017","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib316","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/593186","article-title":"Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease","volume":"47","author":"Mart\u00ednez-Solano","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib317","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7904","article-title":"Inhaled immunoantimicrobials for the treatment of chronic obstructive pulmonary disease","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2025.101616_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113953","article-title":"Mesoporous silica nanoparticles for pulmonary drug delivery","volume":"177","author":"Garc\u00eda-Fern\u00e1ndez","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib319","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000756","article-title":"Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review","volume":"7","author":"Patel","year":"2020","journal-title":"BMJ Open Resp. Res."},{"issue":"21","key":"10.1016\/j.mtbio.2025.101616_bib320","first-page":"385","article-title":"Bronchial asthma: diagnosis and long-term treatment in adults","volume":"105","author":"Ukena","year":"2008","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1016\/j.mtbio.2025.101616_bib321","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2147\/IJN.S441345","article-title":"Preparation of budesonide-loaded liposomal nanoparticles for pulmonary delivery and their therapeutic effect in OVA-induced asthma in mice","volume":"19","author":"Zuo","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib322","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.rmed.2006.10.009","article-title":"Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence","volume":"101","author":"Volovitz","year":"2007","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib323","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation","volume":"42","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.mtbio.2025.101616_bib324","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2024.01.044","article-title":"Airway epithelial-targeted nanoparticle reverses asthma in inhalation therapy","volume":"367","author":"Yu","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib325","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1080\/21655979.2021.1988364","article-title":"Solid lipid nanoparticle delivery of rhynchophylline enhanced the efficiency of allergic asthma treatment via the upregulation of suppressor of cytokine signaling 1 by repressing the p38 signaling pathway","volume":"12","author":"Lv","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.mtbio.2025.101616_bib326","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2022.10.020","article-title":"Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment","volume":"352","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mtbio.2025.101616_bib327","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2023.105634","article-title":"Chitosan: a review on properties, biological activities and recent progress in biomedical applications","volume":"191","author":"Harugade","year":"2023","journal-title":"React. Funct. Polym."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib328","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10096-021-04183-9","article-title":"Therapeutic efficacy of chitosan nanoparticles loaded with BCG-polysaccharide nucleic acid and ovalbumin on airway inflammation in asthmatic mice","volume":"40","author":"Yang","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib329","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1080\/21655979.2021.1940622","article-title":"Self-assembled chitosan nanoparticles for intranasal delivery of recombinant protein interleukin-17 receptor C (IL-17RC): preparation and evaluation in asthma mice","volume":"12","author":"Lv","year":"2021","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib330","doi-asserted-by":"crossref","first-page":"11161","DOI":"10.1021\/acsnano.2c03993","article-title":"Mucoadhesive, antibacterial, and reductive nanogels as a mucolytic agent for efficient nebulized therapy to combat allergic asthma","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib331","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mabi.201100102","article-title":"A potential nanomedicine consisting of heparin-loaded polysaccharide nanocarriers for the treatment of asthma","volume":"12","author":"Oyarzun-Ampuero","year":"2012","journal-title":"Macromol. Biosci."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib332","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2008.09.020","article-title":"Chitosan\/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro","volume":"71","author":"Teijeiro-Osorio","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib333","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40489-8","article-title":"Efficacy and safety of inhaled heparin in asthmatic and chronic obstructive pulmonary disease patients: a systematic review and a meta-analysis","volume":"13","author":"Ashmawy","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib334","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199307083290204","article-title":"Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin","volume":"329","author":"Ahmed","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mtbio.2025.101616_bib335","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1164\/ajrccm.153.5.8630624","article-title":"Time course of the protective effect of inhaled heparin on exercise-induced asthma","volume":"153","author":"Garrigo","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib336","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.724525","article-title":"Berberine-loaded biomimetic nanoparticles attenuate inflammation of experimental allergic asthma via enhancing IL-12 expression","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.mtbio.2025.101616_bib337","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214427","article-title":"Recent advances in nanomaterials for asthma treatment","volume":"23","author":"Zuo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.101616_bib338","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2021.08.024","article-title":"Exosome membrane-modified M2 macrophages targeted nanomedicine: treatment for allergic asthma","volume":"338","author":"Pei","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mtbio.2025.101616_bib339","article-title":"\u03b2-glucan nanoparticles alleviate acute asthma by suppressing ferroptosis and DNA damage in mice","volume":"02013\u20139","author":"Ebeed","year":"2024","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib340","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00204-015-1468-y","article-title":"Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system","volume":"90","author":"Rubio","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.mtbio.2025.101616_bib341","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fbioe.2019.00406","article-title":"Nanomedicine approaches for the pulmonary treatment of cystic fibrosis","volume":"7","author":"Velino","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib342","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.ymthe.2018.05.014","article-title":"Lipid nanoparticle-delivered chemically modified mRNA restores chloride secretion in cystic fibrosis","volume":"26","author":"Robinson","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101616_bib343","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double\u2010blind, placebo\u2010controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib344","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mtbio.2025.101616_bib345","article-title":"Nanoparticle-based platforms for targeted drug delivery to the pulmonary system as therapeutics to curb cystic fibrosis: a review","volume":"217\u2013218","author":"Rano","year":"2024","journal-title":"J. Microbiol. Methods"},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib346","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/alr.23301","article-title":"Glutathione and bicarbonate nanoparticles improve mucociliary transport in cystic fibrosis epithelia","volume":"14","author":"Cho","year":"2024","journal-title":"Int. Forum Allergy & Rhinology"},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib347","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101292","article-title":"Highly branched poly \u03b2-amino ester\/CpG-depleted CFTR plasmid nanoparticles for non-viral gene therapy in lung cystic fibrosis disease","volume":"32","author":"Qiu","year":"2024","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"10.1016\/j.mtbio.2025.101616_bib348","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.2147\/IJN.S30428","article-title":"Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib349","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10753-020-01181-5","article-title":"A20-OVA nanoparticles inhibit allergic asthma in a murine model","volume":"43","author":"Luo","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.mtbio.2025.101616_bib350","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.04.009","article-title":"Therapeutic potential of andrographolide-loaded nanoparticles on a murine asthma model","volume":"20","author":"Chakraborty","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib351","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1016\/j.sjbs.2021.04.009","article-title":"Study effect of Baicalein encapsulated\/loaded Chitosan-nanoparticle on allergic Asthma pathology in mouse model","volume":"28","author":"Wang","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib352","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201603070","article-title":"Local effects on airway inflammation and systemic uptake of 5 nm PEGylated and citrated gold nanoparticles in asthmatic mice","volume":"13","author":"Omlor","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.101616_bib353","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/antiox11091659","article-title":"Gold nanoparticles inhibit steroid-insensitive asthma in mice preserving histone deacetylase 2 and NRF2 pathways","volume":"11","author":"Serra","year":"2022","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.mtbio.2025.101616_bib354","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1038\/emm.2016.89","article-title":"A novel anti-IL4R\u03b1 nanoparticle efficiently controls lung inflammation during asthma","volume":"48","author":"Halwani","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.mtbio.2025.101616_bib355","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.nano.2016.06.008","article-title":"Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases","volume":"12","author":"Vij","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.mtbio.2025.101616_bib356","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2147\/IJN.S59394","article-title":"MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles","volume":"9","author":"Al Faraj","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib357","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijpharm.2018.04.030","article-title":"Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases","volume":"545","author":"De Leo","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib358","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1039\/D3BM01210G","article-title":"Rapamycin-based inhaled therapy for potential treatment of COPD-related inflammation: production and characterization of aerosolizable nano into micro (NiM) particles","volume":"12","author":"Craparo","year":"2024","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib359","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1021\/mp900138a","article-title":"Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin","volume":"7","author":"Cartiera","year":"2010","journal-title":"Mol. Pharm."},{"issue":"47","key":"10.1016\/j.mtbio.2025.101616_bib360","doi-asserted-by":"crossref","first-page":"eabc5911","DOI":"10.1126\/sciadv.abc5911","article-title":"Engineered mutant \u03b1-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis\u2013based cell and mice models","volume":"6","author":"Mukherjee","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2025.101616_bib361","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2019.01.025","article-title":"Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers","volume":"296","author":"Garbuzenko","year":"2019","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101616_bib362","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1021\/acsanm.4c01379","article-title":"Lung disease management by iloprost-loaded nanoparticles to address hyperinflammation associated with cystic fibrosis","volume":"7","author":"Craparo","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.mtbio.2025.101616_bib363","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123644","article-title":"Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models","volume":"649","author":"Kaur","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.101616_bib364","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1183\/23120541.00733-2020","article-title":"Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models","volume":"7","author":"Liu","year":"2021","journal-title":"ERJ Open Res."},{"issue":"3","key":"10.1016\/j.mtbio.2025.101616_bib365","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1471-4892(01)00047-9","article-title":"Monoclonal antibodies as a strategy for pulmonary diseases","volume":"1","author":"Torphy","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.101616_bib366","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/19420862.2016.1196521","article-title":"Therapeutic monoclonal antibodies for respiratory diseases: current challenges and perspectives, March 31 - April 1, 2016, Tours, France","volume":"8","author":"Desoubeaux","year":"2016","journal-title":"mAbs"},{"key":"10.1016\/j.mtbio.2025.101616_bib367","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2019.08.003","article-title":"VEGF and FGF-2: promising targets for the treatment of respiratory disorders","volume":"156","author":"Laddha","year":"2019","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.mtbio.2025.101616_bib368","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.tranon.2019.04.022","article-title":"Limitations of anti-angiogenic treatment of tumors","volume":"12","author":"Ribatti","year":"2019","journal-title":"Translational Oncology"},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib369","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2025.101616_bib370","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1465-9921-7-128","article-title":"Clinical implications for vascular endothelial growth factor in the lung: friend or foe?","volume":"7","author":"Papaioannou","year":"2006","journal-title":"Respir. Res."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425001747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425001747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T08:16:24Z","timestamp":1744964184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425001747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":370,"alternative-id":["S2590006425001747"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.101616","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.101616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101616"}}